IT’S MUSTACHE SEASON.
Celebrate Movember with precise prostate cancer treatments
ACCURAY DELIVERS CLINICAL ADVANTAGES, PATIENT-FOCUSED BENEFITS
You can’t treat prostate cancer with a one-size-fits all solution. It’s not just that every patient is unique – the prostate itself can move unpredictably throughout the course of treatment due to normal patient bodily functions such as filling of the bladder, gas in the bowel, or even slight patient movement during the procedure. Accuray’s innovations give clinicians an unmatched ability to deliver highly precise and efficient treatments that correct for prostate motion in real time – minimizing side effects, improving quality of life and getting patients back to their everyday lives sooner.
Prostate Cancer Webinars
Intensity-Modulated Fractionated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Findings from an International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial
Nicholas van As, M.D. | Royal Marsden Hospital, London, UK
SBRT as a Salvage Option for Localized Recurrent Prostate Cancer
Donald Fuller, M.D. | Genesis Healthcare Partners, San Diego, CA, USA
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
Michael Repka M.D. | Medstar Georgetown University Hospital, Washington, DC (Currently at NYU Langone Health, New York, NY, USA
Safe and Effective Stereotactic Body Radiation Therapy (SBRT) for High-Risk Prostate Cancer Patients: 4-year Outcomes of a Phase II Trial
Victor Macias Hernandez, M.D., Ph.D. | Salamanca University Hospital, Valladolid University Hospital, Spain
The CyberKnife® System
The CyberKnife System is commonly used to treat low- to intermediate-risk prostate cancer and is the only radiotherapy device supported by years of published clinical follow-up with a large number of patients.
These studies provide reassurance to patients and providers that excellent clinical results are reproducible at any CyberKnife center
A CyberKnife® Patient Story
Dr. Robert Meier and CyberKnife® patient Mike “Bing” Crosby take to the air to discuss CyberKnife System treatments for low- to intermediate-risk prostate cancer.
Real-World Clinical Support
Listen to the medical team at the Geisinger Cancer Care about their experience with the CyberKnife S7 System.
The TomoTherapy® and Radixact® Systems
An ideal clinical solution for routine and complex prostate cancer treatments.
Treating Prostate Cancer with the Radixact System and Synchrony®
Read how Synchrony enables personalized real-time adaptive delivery of radiation treatment with the Radixact System to targets while they are in motion by synchronizing the delivery beam position to the target location precisely and accurately during continuous delivery of a treatment fraction.
Treating Prostate Cancer with the TomoTherapy® System
Dr. Nadia Di Muzio of the OSR – San Raffaele Scientific Institute, Milan, Italy discusses the use of helical IG-IMRT to treat prostate cancer patients.